Chin Hairs in Perimenopause Do Not Necessarily Mean High Testosterone

On October 21, 2026, Prevention published dermatologist Mona Gohara’s explanation of why a few coarse chin hairs may appear around perimenopause. Gohara is a board-certified dermatologist and associate clinical professor of dermatology at Yale School of Medicine.

Does this change the medical understanding of menopause hair growth?

Existing menopause guidance already recognises unwanted facial hair as a possible part of hormonal change. The American Academy of Dermatology notes that falling female-hormone levels can be associated with hair under the chin or along the jawline. Hair above the lip can become noticeable too.

Gohara’s explanation adds detail about how individual follicles respond. It does not overturn that understanding or establish that every new chin hair has a hormonal cause.

The Prevention article is expert commentary rather than a clinical trial or new medical guideline. It provides neither a diagnostic testing pathway nor a measured definition of rapid growth. Its value is in explaining the distinction between a common physical change and a pattern that deserves medical attention.

Why can a few chin hairs become thicker?

Gohara told Prevention that the answer involves both the responsiveness of the follicle and the balance between estrogen and androgens:

• Chin and jawline follicles are particularly responsive to androgens. These hormones can influence whether a fine hair remains fine or becomes a thicker terminal hair. Gohara identifies this sensitivity as part of the explanation for coarse hairs in these areas.
• Fine hairs can become darker and more substantial. The article describes a change from vellus hair, often called peach fuzz, to terminal hair. This helps explain why an individual hair can become much more noticeable than the fine hairs around it.
• A changing hormone balance is not the same as high testosterone. According to the article, declining estrogen in midlife can make androgen effects on facial hair more apparent. That relative shift does not necessarily mean testosterone itself is elevated.
• A few coarse hairs can occur with normal hormone levels. Gohara describes a small number of these hairs as normal and harmless. Their presence alone does not establish that someone has a hormone disorder.

The useful distinction is between what a follicle is doing and what that observation proves. A coarse chin hair is a visible change. It is not a measurement of testosterone and does not identify its own cause.

That distinction also matters when reading about hormonal change across midlife. A possible connection with perimenopause deserves context rather than being treated as a complete explanation.

Does every new chin hair come from perimenopause?

No. The Prevention article identifies several possible contributors beyond the menopausal transition. Its broader list is a reason to keep the explanation open rather than deciding that age alone accounts for the change.

• Genetics can contribute. The article includes genetics among the possible explanations for facial hair. A midlife hormone explanation is therefore one possibility within a wider picture, not the only explanation available.
• Other hormonal changes can play a part. Pregnancy-related hormonal changes are another contributor named in the article. This places facial-hair changes in a broader hormonal context rather than making them specific to perimenopause.
• Medication history can be relevant. Testosterone and oral minoxidil are among the medications the article identifies. Their inclusion supports discussing relevant medication use with a clinician rather than interpreting the hair in isolation.
• Other hormone conditions may need attention. The article mentions PCOS as a possible concern when facial-hair changes occur with other symptoms. It does not present a few isolated hairs as a diagnosis of PCOS.

For readers trying to understand a changing body, this is a useful boundary. Perimenopause may offer a plausible explanation without accounting for every change. The purpose of a medical conversation is to place the hair growth within the person’s wider circumstances rather than attach a label from appearance alone.

Which changes deserve a medical conversation?

Gohara recommends discussing new or increasing facial hair with a doctor. The Prevention article draws particular attention to the pace of change and whether other symptoms are appearing alongside it:

• New or increasing growth deserves discussion. The recommendation is not limited to someone with extensive facial hair. A change from a person’s usual pattern is relevant information for a clinician, without automatically establishing a disorder.
• Accompanying symptoms add context. The article specifically names irregular periods, acne and scalp-hair thinning. When these occur alongside new or increasing facial hair, Gohara recommends a conversation with a doctor rather than assuming the changes all have the same cause.
• Sudden or quickly progressing growth deserves timely evaluation. The article advises seeking medical assessment when hair appears suddenly or increases quickly. This is a different message from its reassurance about a few isolated coarse hairs.

A useful account for an appointment can stay straightforward: whether the hair is new or longstanding, whether it is increasing and whether other changes have appeared. Those observations reflect the distinctions Gohara makes. They are information for a clinical conversation rather than a way to diagnose a hormone condition at home.

There is no need to make the concern sound more dramatic for it to be worth mentioning. Gohara’s recommendation includes new or increasing growth. At the same time, the presence of a few hairs should not be translated into certainty about high testosterone or PCOS.

The practical message is to describe the pattern rather than arrive with a conclusion. A clinician can then assess the change in its wider context. Questions about what it means and questions about whether to remove the hair can be addressed separately.

Does removing the hair change the medical question?

Hair removal and medical evaluation serve different purposes. Prevention discusses cosmetic options, but choosing how to manage an unwanted hair does not explain why it appeared or settle whether a changing pattern needs assessment.

• Shaving does not make hair grow back thicker. The article also states that shaving does not make regrowth darker or more plentiful. It may leave a blunt-feeling regrowth, which is different from changing the amount or thickness of hair produced.
• Skin irritation belongs in the decision. Waxing and depilatory creams may irritate skin, according to the article. It highlights particular caution when topical active ingredients such as retinoids are also being used. Suitability is a question for qualified advice rather than a universal recommendation.
• Several approaches exist without one being prescribed for everyone. The article mentions tweezing and shaving alongside professional treatments and prescription approaches. Medication choices belong with a clinician. The discussion does not make any one option necessary for a few isolated hairs.

Removing a hair does not require treating it as a medical problem. Equally, wanting it removed does not make a concern about new growth trivial. Appearance and comfort are legitimate parts of the conversation without being evidence of disease.

Keeping those questions separate allows room for both reassurance and appropriate assessment. Someone may want cosmetic help with a harmless change. Someone noticing sudden progression may need a medical discussion regardless of whether she wants the hair removed.

A straightforward approach to midlife skin care can sit alongside that cosmetic decision. The aim need not be a more complicated routine or a demand to correct every visible sign of change.

What should this mean for future care?

The clinical value of this explanation is a more precise conversation about follicle sensitivity, the pace of change and accompanying symptoms rather than an automatic assumption of high testosterone.

How Refemina helps

Interpreting a new chin hair without automatically labelling it hormonal is the decision here; Refemina places that question within the wider experience of midlife. Its research-led coverage links skin and hair with hormonal transition, helping women facing competing explanations understand where several contributors may be involved.

Explore Resources

Sources

1. A Derm Explains Why That Long Dark Hair Grows on Your Chin—and Nowhere Else
2. www.aad.org › public › everyday-careCaring for your skin in menopause - American Academy of ...